Deep Knowledge Group
Co-Founder / Managing Partner
Longevity.Capital / Co-Founder
Longevity International Association / Co-Founder
Swiss Longevity Valley / Co-Founder of the Project
Dmitry Kaminskiy is an innovative entrepreneur, investor, author and philanthropist dedicated to impact investment and ethical business, with a focus on engineering the accelerated trajectory of progressive technological development for the benefit of humanity.
Mr. Kaminskiy is a Сo-Founder and managing partner of Deep Knowledge Group - a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, policy and philanthropy.
He leads the activities of the consortium’s venture arms - Deep Knowledge Ventures, an investment fund focused on DeepTech and advanced science projects, and Longevity.Capital, which prioritizes the convergence of Longevity and Artificial Intelligence, areas in which it has unparalleled investment and exit strategies.
Mr. Kaminskiy is a frequent speaker on the topics of AI and Longevity at conferences organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, at the Future Finance Forum in Seoul “AI in Finance”, “Precision Medicine World Conference" in Silicon Valley, as well as several others at Oxford and Cambridge Universities.
He was actively involved in the work of the initiative group and was instrumental at the initial stage of the launch of Longevity International CIC, the secretariat for the All-Party Parliamentary Group for Longevity in the UK Parliament (the world's first Longevity-focused parliamentary group), and served as a Co-Founder of the APPG’s Secretariat from 2019-2021.
Mr. Kaminskiy is also Co-Founder of Aging Analytics Agency, Deep Knowledge Group’s dedicated Longevity-focused analytical subsidiary, which currently serves as an official member organisation of the United Nations NGO Committee on Ageing and regularly submits policy and strategy proposals to the World Health Organization, World Economic Forum, the UK House of Lords and other national and international policy organizations.
He also supervises the activities of Deep Knowledge group’s 10+ other analytical subsidiaries, including Deep Knowledge Analytics, Deep Pharma Intelligence, NeuroTech Analytics, FemTech Analytics, SpaceTech Analytics, InvestTech Advanced Solutions, Longevity Financial Advisors, Deep Knowledge Analytics GovTech / E-Governance Division, Deep Knowledge Analytics COVID-19 Analytics Division, and Innovation Eye (a joint venture between Deep Knowledge Analytics and Big Innovation Centre, the Secretariat for the UK All-Party Parliamentary Groups on Artificial Intelligence and Blockchain).
In addition to his business activities, Dmitry is involved in several scientific endeavors. He strongly believes that humans should live longer healthier lives. He has a major interest in Healthy Longevity which is reflected in his business, research and public activities.
His $1 million prize for the first person to reach their 123rd birthday went viral, and was widely covered by the world’s top media. The current lifespan record is 122.5 years, achieved by Jeanne Calment in 1997, which has remained unchanged despite the tremendous advances in biomedicine and in our understanding of the aging process that have occurred since that time.
He chose to launch this prize in order to promote Healthy Longevity, and to motivate people to maximize their own Healthy Longevity. Given the dynamic of progress in the field of Longevity, it is only a matter of time before this record is surpassed through the proactive efforts of someone using all available resources, both scientific, technological and lifestyle-related, to maximize their Healthy Longevity and celebrate his or her 123rd birthday.
Mr. Kaminskiy is also author of the critically acclaimed book, Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History, published in 2020, which distilled the complex assembly of deep market intelligence and industry knowledge that Deep Knowledge Group and its Longevity-focused subsidiaries have developed over the past 7 years into a full-scope understanding of the Global Longevity Industry, sufficient to define the industry for the first time and to reliably forecast its future development. His newest book, Biomarkers of Human Longevity: Data Science for Accelerating Aging Research and R&D and The Critical Catalyst for Practical Human Longevity, Tangible Investment Decision Making and De-Risking, was published 2021.
Dmitry is also the author of a full-fledged Longevity Book Series, comprising a number of upcoming titles including Longevity Financial Industry: Health as New Wealth, Longevity FinTech, WealthTech, InvestTech, InsurTech, AgeTech and the Coming Rise of Longevity Banks, Investment Banks, Stock Exchanges, ETFs, Indices and Novel Financial Instruments and Derivatives, Longevity Politics: Longevity Technocracy, Modern Approaches to Policy, Governance and National Industrial Strategies, and Longevity as the New Political Priority of the 21st Century, and Practical Longevity: The Complete Guide on How to celebrate Your 123rd Birthday, and culminating in the 2022 release of its formal sequel, Longevity Industry 2.0: DeepTech Engineering the Accelerated Trajectory of Human Longevity: The Blueprint and Pathway from Longevity Industry 1.0 to 2.0.
Mr. Kaminskiy adheres to the principal of “Impact Investing” in all his business activities, believing that business should intentionally make a significant impact for social good. He operates according to the maxim that business should be aligned with societal good and humanitarianism, and his activities in both business and the non-profit sector are aimed at the shared goal of advancing exponential and disruptive technologies to accelerate positive paradigm shifts in finance, healthcare and AI.
Deep Knowledge Group www.dkv.global
Deep Knowledge Group is a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, media, philanthropy and more.
Deep Knowledge Ventures www.dkv.global/investments
Data Science driven investment fund focused on strategically-timed investments at the inflection point of technological megatrends, investing in the synergetic convergence of specific DeepTech verticals. The fund is internationally renowned for its use of sophisticated analytical systems for investment target identification and due-diligence.
Longevity.Capital is a specialized Investment Platform which prioritizes the convergence of Longevity and Artificial Intelligence, areas in which it has unparalleled investment and exit strategies, offering direct investment opportunities, tradeable certificates and investment funds focus on the Longevity Industry. The fund is a subsidiary fund of Deep Knowledge Ventures, powered by comprehensive multidimensional analytical systems developed by Aging Analytics Agency to structure advanced investment strategy, sophisticated due diligence operations and pragmatic portfolio companies valuation procedures.
Deep Knowledge Group Analytical Subsidiaries www.dkv.global/analytics
Deep Knowledge Group’s long-term strategy is informed by the quantitative multidimensional analytics, forecasting and benchmarking of its 10+ analytical subsidiaries, which include Deep Knowledge Analytics, Aging Analytics Agency, Deep Pharma Intelligence, NeuroTech Analytics, FemTech Analytics, SpaceTech Analytics, InvestTech Advanced Solutions, Longevity Financial Advisors, Deep Knowlecdge Analytics GovTech / E-Governance Division, Deep Knowledge Analytics COVID-19 Analytics Division, and Innovation Eye.
Aging Analytics Agency www.aginganalytics.com
Aging Analytics Agency is the world’s premier provider of industry analytics on the topics of Longevity, Precision Preventive Medicine and Economics of Aging, and the convergence of technologies such as AI, Blockchain, Digital Health and their impact on the healthcare industry. The company provides strategic consulting services in fields relating to Longevity, and currently serves as the primary source of analytics and data for the UK All-Party Parliamentary Group for Longevity.
Biogerontology Research Foundation www.bg-rf.org.uk
The Biogerontology Research Foundation is the UK’s oldest Longevity-focused charity, founded in 2008 with the aim of accelerating the paradigm shift from disease treatment to personalized precision prevention across science, industry, academia, policy and governance. It was the main initial donor that provided financial and organisational support to Longevity International UK for the purpose of establishing the UK All-Party Parliamentary Group for Longevity. It was also actively involved in the successful initiative of adding a new extension code for “ageing-related diseases” (XT9T) accepted in 2018 by the World Health Organization during the last revisions of its International Classification of Diseases framework.
Deep Knowledge Philanthropy www.deep-knowledge.org
Deep Knowledge Philanthropy is a data-driven non-profit project by Deep Knowledge Group committed to the support, development and advancement of DeepTech for social good, impact philanthropy and ethical investment, founded on the belief that DeepTech innovation is the most efficient driver of ‘social profit’, technological humanitarianism, and societal development, and that venture philanthropy is the profitable long-term investment for individuals, national economies, and humanity itself.
Swiss Longevity Valley www.longevitysuisse.org
Swiss Longevity Valley is a leading Longevity Policy Hub and Think Tank, part of Deep Knowledge Group's consortium, working to leverage the national strengths and potentials of Switzerland in order to transform the nation into a world-leading Longevity Hub through cooperation, coordination and partnerships with Swiss Government Agencies and Representatives to develop innovative Longevity Policy Strategy. Swiss Longevity Valley is dedicated to turning Switzerland into an International Longevity, Preventive Medicine and Precision Health Hub via leveraging its unique strengths in international policy, finance, AI and Preventive Medicine.
5th Industrial Revolution International www.5revolution.tech
5th Industrial Revolution International is a UK-based social enterprise working to forecast, analyze, benchmark and implement in practice the most realistic methods of optimizing the trajectory technological progress (and the ongling evolution of DeepTech and Frontier Technologies in particular, which arepoised at the exact intersection of the most multidimensional domains of human existence, including science, technology, and policy.) and maximizing the safe, socially inclusive delivery of its benefits for global humanity.
Longevity International Association is a Swiss-based non-profit dedicated to promoting more efficient and intelligent collaboration, cooperation, and productive discussion among Longevity Industry participants and stakeholders, including companies, investors, non-profits, academic labs and R&D hubs, governmental bodies and policy makers, to accelerate and democratize Longevity industry collaboration and harmonization, as well as the socially-inclusive delivery of its humanitarian benefits and dividends for global society.
Longevity Books is a dedicated series of domain-specific books on different areas of the Global Longevity Industry authored by Deep Knowledge Group General Partner Dmitry Kaminsky. These include his critically acclaimed first book, Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History, his second book, Biomarkers of Human Longevity: Data Science for Accelerating Aging Research and R&D and The Critical Catalyst for Practical Human Longevity, Tangible Investment Decision Making and De-Risking, and a number of subsequent domain-specific books scheduled for publication in 2022 and beyond: Longevity Financial Industry, Longevity Politics: Practical Longevity and Longevity Industry 2.0: DeepTech Engineering the Accelerated Trajectory of Human Longevity: The Blueprint and Pathway from Longevity Industry 1.0 to 2.0.
Deep Knowledge Ventures flagship AI-for-drug-discovery portfolio company, applying AI and Deep Learning for drug discovery development of biomarkers of aging. Deep Knowledge Ventures provided Insilco Medicine with its seed financing in 2014, an the company has since gone on to raise more than $300 million in follow-on funding from a wide range of prominent VC funds, institutional investors and sovereign wealth funds.